Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
Scope of the Report:
The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.
The worldwide market for Scopolamine is expected to grow at a CAGR of roughly 3.8% over the next five years, will reach 20 million US$ in 2024, from 16 million US$ in 2019, according to a new WMR study.
This report focuses on the Scopolamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Alkaloids of Australia
Fine Chemicals Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Scopolamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Scopolamine, with price, sales, revenue and global market share of Scopolamine in 2017 and 2018.
Chapter 3, the Scopolamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Scopolamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Scopolamine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Scopolamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.